PGS Testing 5th Day Biopsy - 12 Embryos

The biopsy is performed by an embryologist in a laboratory setting. On the 5th day of development, a small number of cells are carefully removed from each embryo. These cells are then analyzed to identify any chromosomal abnormalities.

PGS testing can be considered by anyone undergoing IVF, particularly those with a history of recurrent miscarriages, failed IVF cycles, genetic disorders, or those of advanced maternal age. However, the decision to undergo PGS testing should be made in consultation with a fertility specialist.

A chromosomally normal (or euploid) embryo is one that contains the correct number of chromosomes - 46 in total, 23 from the egg and 23 from the sperm. Embryos with the correct number of chromosomes are more likely to result in a successful pregnancy and a healthy baby.

If an abnormality is detected, that particular embryo would not be selected for transfer. The decision to proceed with the transfer of any remaining normal embryos would be made in consultation with your fertility specialist.

Yes, because PGS testing involves the analysis of chromosomes, it can identify the sex of the embryos. However, it's important to note that the primary goal of PGS testing is to identify chromosomally normal embryos, and not to select the sex of the baby.

The results of PGS testing are usually available within 7-10 days. During this waiting period, the embryos are cryopreserved (frozen) and stored safely until the results are available.

PGS testing is a highly accurate method of detecting chromosomal abnormalities. However, like all tests, it's not 100% accurate and there's a small chance that the test could miss an abnormality or produce a false-positive result.

The biopsy process involves removing a small number of cells from each embryo, which does not typically harm the embryos. However, the procedure should be performed by a skilled embryologist to minimize any potential risk.

The main risk associated with PGS testing is the potential for damage to the embryos during the biopsy process. However, this risk is minimal when the procedure is performed by a skilled embryologist.

While PGS testing can significantly increase the chances of a successful pregnancy by ensuring only chromosomally normal embryos are transferred, it does not guarantee a pregnancy. Other factors, such as the health and age of the woman, also play important roles.

PGS testing can identify a wide range of chromosomal abnormalities, but it cannot detect all genetic disorders. Some genetic disorders are caused by single gene mutations that are not detectable by PGS testing.

Yes, PGS testing can be performed on frozen embryos. The embryos would be thawed, biopsied, and then refrozen until the results are available.

No, PGS testing itself does not increase the chance of having twins or multiples. However, the transfer of multiple embryos can increase the chance of a multiple pregnancy.

While both PGS and PGD involve genetic testing of embryos, they are used for different purposes. PGS is used to screen for chromosomal abnormalities in embryos, while PGD is used to identify specific genetic disorders in embryos when one or both parents are known to be carriers of the disorder.